• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Vasectomy Market Share

    ID: MRFR/MED/3282-HCR
    110 Pages
    Rahul Gotadki
    October 2025

    Vasectomy Market Research Report Information By Type (Conventional Vasectomy, No-Scalpel Vasectomy, Minimally Invasive Vasectomy), Drug (Anesthetics, Painkillers, Antibiotics), Patient (Humans, Animals), End User (Hospitals And Clinics) - Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Vasectomy Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Share

    Vasectomy Market Share Analysis

    The reproductive health industry's vasectomy business is small but important since it includes male sterilization. Cultural perspectives, accessibility, and technology advances affect the permanent contraceptive industry. As more men choose vasectomy, the market for this safe and efficient birth control treatment has grown. Businesses seeking strategic positioning must comprehend market size and growth. Vasectomy companies engage in research and development to make operations less invasive and more convenient. Technology improves patient satisfaction and may induce more people to get vasectomy for birth control. Since vasectomy is irreversible, education is crucial to market share positioning. Businesses prioritize comprehensive educational programs for healthcare professionals and the public. Provide patients with facts on surgical safety, effectiveness, and reversibility to dispel myths. Building relationships with healthcare professionals is crucial. Companies teach medical personnel to perform vasectomy procedures properly. Collaboration with healthcare experts may also create a patient referral and endorsement network. Making vasectomy affordable is crucial to market entry. Companies are attempting to get insurance coverage for the therapy, remove financial barriers, and increase the number of individuals contemplating vasectomy for birth control. Businesses must understand the demographic factors that drive vasectomy decisions to adapt their marketing strategies. Tailoring marketing and outreach by age, culture, and socioeconomic status may be more successful. Companies consider global expansion, taking cultural and legal differences into consideration. Adapting one's approach to other places' demands and cooperating with foreign healthcare providers might help expand one's market reach. Offering post-vasectomy care and assistance sets you apart from competition. Businesses are developing follow-up instructions, fixing concerns, and offering vasectomy reversal to boost patient satisfaction and loyalty. Partnerships with NGOs and government health programs may boost market position. Collaborations may include raising awareness, funding marginalized group processes, and supporting larger-scale family planning operations. Successful market entry and success need regulatory framework navigation. Companies prioritize compliance with local and international laws, which compel them to ensure their products and services meet quality and safety requirements. Data analytics for market trends, patient outcomes, and competitor behavior is a key component of adaptive tactics. To be alert and adaptable to vasectomy market changes, companies invest in thorough monitoring systems.

    Market Summary

    As per Market Research Future Analysis, the global vasectomy market is projected to grow at a CAGR of 7.4%, reaching a value of USD 27.46 billion from 2023 to 2032. Vasectomy is a permanent male sterilization procedure that effectively prevents pregnancy by cutting and sealing the vas deferens. The procedure is minimally invasive, typically completed in under 30 minutes, and allows patients to resume normal sexual activity within a week. The market is driven by increasing global population, hormonal disturbances, and rising gender equality, while challenges include the impact of COVID-19 on production and supply chains. The market is segmented by type, drugs, end-users, patients, and regions, with North America holding the largest market share due to high demand and advanced medical infrastructure.

    Key Market Trends & Highlights

    Key trends influencing the vasectomy market include technological advancements and changing societal attitudes towards male contraception.

    • Market expected to grow at a CAGR of 7.4% from 2023 to 2032.
    • North America holds the largest market share due to gender equality and healthcare demand.
    • COVID-19 pandemic significantly impacted production and supply chains.
    • Emerging technologies are creating new opportunities in the vasectomy market.

    Market Size & Forecast

    Market Size USD 27.46 Billion by 2032
    CAGR 7.4%
    Largest Regional Market North America
    Market Segmentation By Type, Drugs, End-User, Patients, Region.

    Major Players

    Key players include Pfizer Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company Inc., Accurate Surgical & Scientific Instruments Corporation, and Sklar Surgical Instruments.

    Market Trends

    The increasing acceptance of vasectomy as a reliable form of contraception reflects a broader trend towards informed reproductive choices among men, suggesting a shift in societal attitudes towards male sterilization procedures.

    U.S. Centers for Disease Control and Prevention (CDC)

    Vasectomy Market Market Drivers

    Market Growth Projections

    The Global Vasectomy Market Industry is projected to experience substantial growth in the coming years. With a current valuation of 16.8 USD Billion in 2024, the market is anticipated to reach 34.0 USD Billion by 2035. This represents a significant increase, driven by various factors including rising awareness of family planning, technological advancements, and changing societal attitudes towards male contraception. The expected compound annual growth rate (CAGR) of 6.63% from 2025 to 2035 further underscores the potential for expansion within this sector. These projections indicate a robust future for the vasectomy market as it adapts to evolving consumer needs and preferences.

    Government Initiatives and Support

    Government initiatives and support play a crucial role in shaping the Global Vasectomy Market Industry. Many countries have implemented policies aimed at promoting family planning and reproductive health services, which include vasectomy. These initiatives often provide funding for educational programs and subsidized healthcare services, making vasectomy more accessible to the public. For instance, countries with robust family planning programs report higher rates of vasectomy acceptance. This governmental backing not only raises awareness but also encourages men to consider vasectomy as a responsible choice, contributing to the projected CAGR of 6.63% for the period from 2025 to 2035.

    Rising Awareness of Family Planning

    The increasing awareness surrounding family planning and reproductive health is a pivotal driver for the Global Vasectomy Market Industry. Educational campaigns and healthcare initiatives have emphasized the importance of responsible parenthood, leading to a growing acceptance of vasectomy as a viable option for permanent contraception. This trend is particularly evident in developed nations, where the demand for vasectomies is on the rise. As of 2024, the Global Vasectomy Market is valued at 16.8 USD Billion, reflecting a shift in societal attitudes towards male sterilization. This awareness is expected to further bolster market growth as more individuals consider vasectomy as a practical solution.

    Changing Attitudes Towards Male Contraception

    Changing attitudes towards male contraception are reshaping the Global Vasectomy Market Industry. Traditionally, contraceptive responsibility has been predominantly placed on women, but there is a noticeable shift as men increasingly recognize the importance of sharing this responsibility. This evolving mindset is fostering a more open dialogue about male sterilization options, including vasectomy. As societal norms continue to evolve, more men are likely to consider vasectomy as a practical and responsible choice. This cultural shift is expected to drive market growth, aligning with the overall trend of increasing acceptance of male contraceptive methods.

    Technological Advancements in Surgical Techniques

    Technological advancements in surgical techniques are significantly influencing the Global Vasectomy Market Industry. Innovations such as no-scalpel vasectomy and advanced anesthesia methods have improved patient experiences and outcomes, leading to increased adoption rates. These minimally invasive procedures reduce recovery times and complications, making vasectomy a more appealing option for men. As healthcare providers adopt these modern techniques, the market is likely to witness a surge in demand. The anticipated growth trajectory suggests that by 2035, the market could reach 34.0 USD Billion, driven by these advancements that enhance the overall efficacy and safety of the procedure.

    Increased Healthcare Access and Insurance Coverage

    Increased healthcare access and insurance coverage are significant factors driving the Global Vasectomy Market Industry. As healthcare systems evolve, more individuals gain access to reproductive health services, including vasectomy. Insurance providers are increasingly covering the costs associated with the procedure, reducing financial barriers for potential patients. This trend is particularly pronounced in regions where healthcare reforms have expanded coverage for family planning services. As a result, more men are likely to opt for vasectomy, contributing to the market's growth trajectory. The combination of improved access and financial support is expected to enhance the overall adoption rates of vasectomy.

    Market Segment Insights

    Regional Insights

    Key Companies in the Vasectomy Market market include

    Industry Developments

    Pfizer Inc. and BioNTech S.E. today announced that they had submitted an application to the U.S. Food and Drug Administration for emergency use authorization of an additional booster dose for the adults. The submission is completely based on the two-real world data sets from Israel.

    Future Outlook

    Vasectomy Market Future Outlook

    The Global Vasectomy Market is projected to grow at a 6.63% CAGR from 2024 to 2035, driven by rising awareness, technological advancements, and increasing demand for permanent contraception.

    New opportunities lie in:

    • Develop innovative minimally invasive vasectomy techniques to enhance patient comfort and recovery.
    • Expand telehealth services for pre- and post-operative consultations to improve accessibility.
    • Invest in educational campaigns targeting younger demographics to increase awareness and acceptance of vasectomy.

    By 2035, the Vasectomy Market is expected to demonstrate robust growth, reflecting evolving societal attitudes towards family planning.

    Market Segmentation

    Vasectomy Market Segmentation

    By Type
    • Conventional Vasectomy
    • No-scalpel Vasectomy
    • Minimally Invasive Vasectomy
    By Drugs
    • Anesthetics
    • Painkillers
    • Antibiotics
    • Others
    By End-User
    • Hospital & Clinics
    • Research and academics
    • Others
    By Patients
    • Human
    • Animals
    By Regional Sectors
    • Asia-Pacific
    • Europe
    • South America
    • North America
    • Middle East & Africa
    Some of the key market players are
    • {"Pfizer Inc."=>[]}
    • Abbott
    • GlaxoSmithKline plc.
    • Sanofi S.A.
    • Novartis AG
    • Bayer AG
    • Bristol Myers Squibb Company
    • Eli Lilly and Company Inc.
    • Accurate Surgical & Scientific Instruments Corporation
    • Sklar Surgical Instruments

    Report Scope

    Attribute/Metric Details
    Market Size 2022 N/A (USD Billion)
    Market Size 2023 N/A (USD Billion)
    Market Size 2032 27.46 (USD Billion)
    Compound Annual Growth Rate (CAGR) 7.4 % (2024- 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2022
    Market Forecast Period 2023 - 2032
    Historical Data 2019 - 2022
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Inc., Accurate Surgical & Scientific Instruments Corporation, Sklar Surgical Instruments, Advanced Meditech International and others
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers Rising demand due to growing population Increasing male-female equality Side effects of female contraception

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. Table Of Content
    2. Report Prologue
    3. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    5. Market Dynamics
      1. Drivers
      2. Restrains
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
      6. Technology Trends & Assessment
    6. Market Factor Analysis
      1. Porters Five Forces Analysis
      2. Value Chain Analysis
      3. Investment Feasibility Analysis
      4. Pricing Analysis
    7. Global Vasectomy Market, By Type
      1. Introduction
      2. Conventional Vasectomy
        1. Market Estimates & Forecast, 2023-2030
      3. No-Scalpel Vasectomy
        1. Market Estimates & Forecast, 2023-2030
      4. Minimally Invasive Vasectomy
        1. Market Estimates & Forecast, 2023-2030
    8. Global Vasectomy Market, By Drugs
      1. Introduction
      2. Anesthetics
        1. Market Estimates & Forecast, 2023-2030
      3. Pain Killers
        1. Market Estimates & Forecast, 2023-2030
      4. Antibiotics
        1. Market Estimates & Forecast, 2023-2030
      5. Others
        1. Market Estimates & Forecast, 2023-2030
    9. Global Vasectomy Market, By Patients
      1. Introduction
      2. Humans
        1. Market Estimates & Forecast, 2023-2030
      3. Animals
        1. Market Estimates & Forecast, 2023-2030
    10. Global Vasectomy Market, By End-User
      1. Introduction
      2. Hospitals And Clinics
        1. Market Estimates & Forecast, 2023-2030
      3. Research And Academics
        1. Market Estimates & Forecast, 2023-2030
      4. Others
        1. Market Estimates & Forecast, 2023-2030
    11. Global Vasectomy Market, By Region
      1. Introduction
      2. Americas
        1. North America
        2. South America
      3. Europe
        1. Western Europe
        2. Eastern Europe
      4. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. Republic Of Korea
        6. Rest Of Asia Pacific
      5. The Middle East & Africa
        1. United Arab Emirates
        2. Saudi Arabia
        3. Oman
        4. Kuwait
        5. Qatar
        6. Rest Of The Middle East & Africa
    12. Company Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development & Strategies
        1. Key Developments
    13. Company Profiles
      1. Pfizer, Inc.
        1. Overview
        2. Product Overview
        3. Financials
        4. Key GlaxoSmithKline Plc
        5. Overview
        6. Product Overview
        7. Financials
        8. Key Developments
      2. Sanofi S.A.
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      3. Accurate Surgical & Scientific Instruments Corporation
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      4. Sklar Surgical Instruments
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      5. Novartis AG
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      6. Abbott
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      7. Advanced Meditech International
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Development
      8. Others
    14. MRFR Conclusion
      1. Key Findings
        1. From CEO’s View Point
        2. Unmet Needs Of The Market
      2. Key Companies To Watch
      3. Prediction Of Vasectomy Industry
    15. Appendix
    16. List of Tables and Figures
      1. List Of Tables
      2. TABLE 1 GLOBAL VASECTOMY MARKET, BY TYPE, 2023-2030 (USD MILLION)
      3. TABLE 2 ASEPTIC ISOLATORS FOR VASECTOMY MARKET, BY REGION, 2023-2030 (USD MILLION)
      4. TABLE 3 CONVENTIONAL VASECTOMY FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      5. TABLE 4 NO-SCALPEL VASECTOMY FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      6. TABLE 5 MINIMALLY INVASIVE VASECTOMY FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      7. TABLE 6 GLOBAL VASECTOMY MARKET, BY DRUGS, 2023-2030 (USD MILLION)
      8. TABLE 7 ANESTHETICS FOR VASECTOMY MARKET, BY REGION, 2023-2030 (USD MILLION)
      9. TABLE 8 PAIN KILLERS FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      10. TABLE 9 ANTIBIOTICS FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      11. TABLE 10 OTHERS FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      12. TABLE 11 GLOBAL VASECTOMY MARKET, BY PATIENTS, 2023-2030 (USD MILLION)
      13. TABLE 12 HUMANS FOR VASECTOMY MARKET, BY REGION, 2023-2030 (USD MILLION)
      14. TABLE 13 ANIMALS FOR VASECTOMY MARKET, BY REGION 2023-2030 (USD MILLION)
      15. TABLE 14 GLOBAL VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
      16. TABLE 15 NORTH AMERICA VASECTOMY MARKET, BY COUNTRY 2023-2030 (USD MILLION)
      17. TABLE 16 NORTH AMERICA VASECTOMY MARKET, BY TYPE 2023-2030 (USD MILLION)
      18. TABLE 17 NORTH AMERICA VASECTOMY MARKET, BY DRUGS 2023-2030 (USD MILLION)
      19. TABLE 18 NORTH AMERICA VASECTOMY MARKET, BY PATIENTS 2023-2030 (USD MILLION)
      20. TABLE 19 NORTH AMERICA VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
      21. TABLE 20 NORTH AMERICA VASECTOMY MARKET BY REGION 2023-2030 (USD MILLION
      22. TABLE 21 EUROPE VASECTOMY MARKET, BY COUNTRY 2023-2030 (USD MILLION)
      23. TABLE 22 EUROPE VASECTOMY MARKET, BY TYPE 2023-2030 (USD MILLION)
      24. TABLE 23 EUROPE VASECTOMY MARKET, BY DRUGS 2023-2030 (USD MILLION)
      25. TABLE 24 EUROPE VASECTOMY MARKET, BY PATIENTS 2023-2030 (USD MILLION)
      26. TABLE 25 EUROPE VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
      27. TABLE 26 EUROPE VASECTOMY MARKET BY REGION 2023-2030 (USD MILLION)
      28. TABLE 27 ASIA PACIFIC VASECTOMY MARKET, BY COUNTRY 2023-2030 (USD MILLION)
      29. TABLE 28 ASIA PACIFIC VASECTOMY MARKET, BY TYPE 2023-2030 (USD MILLION)
      30. TABLE 29 ASIA PACIFIC VASECTOMY MARKET, BY DRUGS 2023-2030 (USD MILLION)
      31. TABLE 30 ASIA PACIFIC VASECTOMY MARKET, BY PATIENTS 2023-2030 (USD MILLION)
      32. TABLE 31 ASIA PACIFIC VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
      33. TABLE 32 ASIA PACIFIC VASECTOMY MARKET BY REGION 2023-2030 (USD MILLION
      34. TABLE 33 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY COUNTRY 2023-2030 (USD MILLION)
      35. TABLE 34 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY TYPE 2023-2030 (USD MILLION)
      36. TABLE 35 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY DRUGS 2023-2030 (USD MILLION)
      37. TABLE 36 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY PATIENTS 2023-2030 (USD MILLION)
      38. TABLE 37 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY END USER, 2023-2030 (USD MILLION)
      39. TABLE 38 MIDDLE EAST & AFRICA VASECTOMY MARKET BY REGION 2023-2030 (USD MILLION List Of Figures
      40. FIGURE 1 RESEARCH PROCESS
      41. FIGURE 2 MARKET DYNAMICS FOR GLOBAL VASECTOMY MARKET
      42. FIGURE 3 GLOBAL VASECTOMY MAKRET, BY SEGMENT, 2023
      43. FIGURE 4 GLOBAL VASECTOMY SUCCESS MARKET, BY REGION
      44. FIGURE 5 GLOBAL VASECTOMY MARKET SHARE, BY TYPE 2023
      45. FIGURE 6 GLOBAL VASECTOMY MARKET SHARE, BY SYSTEM 2023
      46. FIGURE 7 GLOBAL VASECTOMY MARKET SHARE, BY PATIENTS 2023
      47. FIGURE 8 GLOBAL VASECTOMY MARKET SHARE, BY END USER, 2023
      48. FIGURE 9 GLOBAL VASECTOMY MARKET SHARE, 2023
      49. FIGURE 10 GLOBAL VASECTOMY MARKET SHARE, BY REGION, 2023
      50. FIGURE 11 NORTH AMERICA VASECTOMY MARKET SHARE, BY COUNTRY, 2023
      51. FIGURE 12 EUROPE VASECTOMY MARKET SHARE, BY COUNTRY, 2023
      52. FIGURE 13 ASIA PACIFIC VASECTOMY MARKET SHARE, BY COUNTRY, 2023
      53. FIGURE 14 MIDDLE EAST & AFRICA VASECTOMY MARKET, BY REGION, 2023
      54. FIGURE 15 GLOBAL VASECTOMY MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
      55. FIGURE 16 ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS CORPORATION.: KEY FINANCIALS
      56. FIGURE 17 ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS CORPORATION.: SEGMENTAL REVENUE
      57. FIGURE 18 ACCURATE SURGICAL & SCIENTIFIC INSTRUMENTS CORPORATION.: GEOGRAPHICAL REVENUE
      58. FIGURE 19 PFIZER, INC.: KEY FINANCIALS
      59. FIGURE 20 PFIZER, INC.: SEGMENTAL REVENUE
      60. FIGURE 21 PFIZER, INC.: GEOGRAPHICAL REVENUE
      61. FIGURE 22 ADVANCED MEDITECH INTERNATIONAL: KEY FINANCIALS
      62. FIGURE 23 ADVANCED MEDITECH INTERNATIONAL: SEGMENTAL REVENUE
      63. FIGURE 24 ADVANCED MEDITECH INTERNATIONAL: GEOGRAPHICAL REVENUE
      64. FIGURE 25 ABBOTT: KEY FINANCIALS
      65. FIGURE 26 ABBOTT: SEGMENTAL REVENUE
      66. FIGURE 27 ABBOTT: GEOGRAPHICAL REVENUE
      67. FIGURE 28 SKLAR SURGICAL INSTRUMENTS: FINANCIAL REVENUE
      68. FIGURE 29 SKLAR SURGICAL INSTRUMENTS: SEGMENTAL REVENUE
      69. FIGURE 30 SKLAR SURGICAL INSTRUMENTS: GEOGRPAHICAL REVENUE

    Vasectomy Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials